Nevro Corp.

Nevro Corp.

NVRO
Nevro Corp.US flagNew York Stock Exchange
5.84
USD
- -
- -
224.09MMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
26.7
34.57
7.34
2.62
8.02
11.1
12.89
12.67
10.75
11.11
11.51
11.82
- -
11.02
Basic EPS, GAAP
-27.9
-38.27
-6.91
-2.54
-1.12
-1.25
-1.64
-3.37
-2.47
-3.77
0.08
-2.56
- -
-3.06
Free Cash Flow per Basic Share
-33.1
-31.11
-7.16
-3.97
-2.17
-0.63
-0.46
-1.74
-0.14
-1.56
0.49
-1.87
- -
-0.79
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-95.59
-134.09
-27.46
-7.12
-7.76
-8.76
-10.18
-13.3
-14.63
-17.92
-17.19
-19.44
- -
-21.92
Tangible Book Value per Share
-90.9
-126.2
38.75
8.83
8.74
8.47
8.17
7.02
11.53
8.72
9.17
6.33
- -
5.57
Basic Weighted Avg Shares
1
1
4
27
28
29
30
31
34
35
35
36
- -
37
Sales/Revenue/Turnover
18
24
33
70
229
327
387
390
362
387
406
425
409
409
Operating Margin (%)
-105.4
-107.03
-86.9
-89.6
-10.1
-9.05
-10.78
-24.72
-17.36
-23.5
-24.32
-23.36
-23.18
-23.18
Depreciation Expense
- -
- -
- -
1
2
3
4
8
8
9
10
12
14
14
Net Income, GAAP
-19
-26
-31
-67
-32
-37
-49
-104
-83
-131
3
-92
-113
-113
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
29.62
- -
- -
- -
Profit Margin (%)
-104.5
-110.7
-94.19
-96.88
-13.91
-11.22
-12.7
-26.57
-22.94
-33.95
0.74
-21.69
-27.77
-27.77
Working Capital
44
67
190
246
378
383
381
351
514
449
484
448
373
373
LT Debt
- -
- -
20
20
138
145
152
181
158
167
197
216
213
213
Total Equity
44
67
172
235
249
249
245
216
388
304
324
293
231
231
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-14.03
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1.74
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Jun'24
Sep'24
Dec'24
ST Debt
38
38
38
LT Borrowings
181
184
188
LT Finance Leases
24
24
26
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
37
37
38
Market Capitalization
307
205
138

Working Capital

FRC

in mil. unless spec.
Jun'24
Sep'24
Dec'24
Total Current Assets
486
479
476
Cash, Cash Equivalents & STI
274
277
293
Accounts Receivable, Net
74
71
72
Inventories
126
120
103
Total Current Liabilities
102
95
103
Payables & Accruals
62
55
63
ST Debt
38
38
38
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.29%
6.74%
-21.2%
Free Cash Flow
63%
49.78%
-56.65%
Net Income, GAAP
-298.65%
-642.75%
23.02%
Sales/Revenue/Turnover
40.96%
1.08%
-3.92%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
88
104
100
114
406
2023
96
109
104
116
425
2024
102
104
97
106
409

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-0.98
-0.71
2.3
-0.54
0.08
2023
-0.98
-0.69
-0.65
-0.25
-2.56
2024
-0.7
-0.53
-0.41
-1.41
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Kevin R. Thornal
Full Time Employees
1,099
Sector
Healthcare
Industry
Medical - Devices
Address
1800 Bridge Parkway Redwood City CA United States of America 94065
IPO Date
Nov 6, 2014
Website
nevro.com
Business
Nevro Corp. (NVRO) develops and commercializes neuromodulation platforms, including its proprietary HFX spinal cord stimulation (SCS) systems, for treating chronic pain of the trunk and/or limbs, non-surgical refractory back pain, and painful diabetic neuropathy; the HFX platform features the Senza SCS system delivering paresthesia-free 10 kHz high-frequency therapy, Senza II and Senza Omnia SCS systems, HFX iQ implantable pulse generator with AI-driven personalization via HFX AdaptivAI launched in 2024, HFX trial stimulator, patient remote, HFX App for wireless trialing, and Surpass surgical and percutaneous leads; it also offers Vyrsa Technologies sacroiliac joint fusion implants acquired in 2023, physician support services including Nevrocloud insights, and patient coaching. The company markets its products through a direct sales force, sales agents, and distributors in the United States, Europe, Australia, and other international markets. Founded in 2006 and headquartered in Redwood City, California, Nevro reports preliminary 2024 revenue of up to $409 million. In February 2025, Globus Medical agrees to acquire Nevro for $250 million in a deal expected to close in the second quarter of 2025, combining Nevro's neurostimulation leadership with Globus's musculoskeletal expertise to expand global patient reach.

Company News

APIChat
  • CSE Bulletin: Delist - EnviroGold Global Limited (NVRO)

  • Unlocking the Future of Metals Supply from Above-Ground Assets

  • EnviroGold Advances NVRO Process™, Broadens Addressable Market

  • EnviroGold Global Announces Strategic Board and Leadership Enhancements to Accelerate Commercialization and Scale Operations

  • EnviroGold Retires Over $10.2 Million in Debt in 2025, Strengthens Balance Sheet as Commercialization Accelerates

  • EnviroGold Increases Size of Previously Announced Non-Brokered Private Placement Due to Strong Investor Demand

  • EnviroGold Closes First Tranche of Non-Brokered Private Placement and Confirms Strong Momentum Toward Final Tranche

  • Nevro Corp. Data Breach - Levi & Korsinsky, LLP Launches Investigation

  • Nevro Corp. Data Breach under Investigation by Levi & Korsinsky, LLP

  • INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Nevro Corp. Data Breach

  • Nevro Corp. Data Breach - Levi & Korsinsky, LLP Launches Investigation

  • Nevro Corp. Data Breach - Levi & Korsinsky, LLP Launches Investigation

  • Nevro Corp. Data Breach Under Investigation by Levi & Korsinsky, LLP

  • INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Nevro Corp. Data Breach

  • Levi & Korsinsky, LLP Investigates Nevro Corp. Data Breach

  • Levi & Korsinsky, LLP Investigates Nevro Corp. Data Breach

  • INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Nevro Corp. Data Breach

  • DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Nevro Corp. Customers Whose Data May Have Been Compromised

  • INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Nevro Corp. Data Breach

  • Nevro Corp. Data Breach - Levi & Korsinsky, LLP Launches Investigation